Analysis examines biomedical prevention technology to be reviewed by U.S. Food and Drug Administration by June 15, 2012 Pre-exposure chemoprophylaxis (PrEP)—taking antiretroviral medications to prevent HIV transmission—could be a “game changer” for HIV prevention. PrEP has demonstrated partial efficacy with men who have sex with men (MSM), transgender women, and heterosexuals in several recent studies. Recent modeling of PrEP implementation coupled with scaled up treatment predicts that PrEP could significantly reduce HIV incidence and prevalence. And if PrEP is accompanied by sustained care, behavioral interventions, and safety monitoring, PrEP need not lead to increased sexual risk behavior or drug resistance.Read More
Subscribe To Fenway Focus
Fenway Health has served the LGBT community, those affected by HIV, and our other members of our community in Boston’s Fenway neighborhood and beyond for the last 40 years. Learn more about Fenway Health; our research arm, The Fenway Institute; and the Sidney Borum, Jr. Health Center, which provides safe, non-judgmental care for young people ages 12–29 who may not feel comfortable going anywhere else.
Affordable Care Act AIDS AIDS2012 AIDS Action Committee AIDS Walk Boston behavioral health bisexual Construction Update Events Fundraisers Gender identity Harbor to the Bay Health care Health Disparities HIV HIV/AIDS HIV/AIDS Policy HIV prevention HIV Research HIV testing International AIDS Conference Lesbian health LGBT advocacy LGBT Aging Project LGBT health LGBT Health Research LGBT seniors LGBT Youth Mentions in the news men who have sex with men National LGBT Health Education Center news Pre-Exposure Prophylaxis PrEP The Fenway Institute trans Transgender Transgender Awareness Week Transgender Health Trans Health Trans Women Health Violence Recovery Program Women's Health Young Leaders Council young people